FilingReader Intelligence

Shanghai RAAS schedules 2024 AGM amidst strategic shifts

April 28, 2025 at 01:11 PM UTCBy FilingReader AI

Shanghai RAAS Blood Products announced it will hold its 2024 Annual General Meeting on May 20, 2025, at 14:00, both in person at the Nanjiao Hotel in Shanghai and via online voting. Shareholders of record as of May 15, 2025, are eligible to attend and vote on resolutions, including the 2024 financial statements, board and supervisory reports, a profit distribution plan, and proposed amendments to the company's articles of association and rules of procedure for the board of directors. Notably, resolutions will address related-party transactions and applications for credit lines from commercial banks. The AGM occurs during a period of strategic transformation for Shanghai RAAS, highlighted by the completion of a strategic collaboration with Haier Group, resulting in Haier controlling 28.22% of voting rights. The company is also executing a share repurchase program, aiming to buy back shares worth between CNY 250 million and CNY 500 million for employee incentives. As of April 7, 2025, the company had cumulatively repurchased 15,649,851 shares at a total cost of CNY 108.43 million. A first-quarter report also highlights sales of CNY 2,005.8 million.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SZSE:002252Shenzhen Stock Exchange
Pharmaceuticals

News Alerts

Get instant email alerts when Shanghai RAAS Blood Products publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →